Form 13-F position report

ABIVAX SA

Reported by Paradigm Biocapital Advisors LP

ABVX CUSIP 00370M103 Manager CIK 0001855655

Reported 0 shares, down 772,473 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q2 2026
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 4 Through Q2 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-09-30 132800240
2025-12-31 191153321
2026-03-31 86014869
2026-06-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for ABIVAX SA held by Paradigm Biocapital Advisors LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 0 -772,473 (-100.0%) 0 $0 2026-08-14
Q1 2026 Reduced 772,473 -645,000 (-45.5%) 1.76% $86,014,869 2026-05-15
Q4 2025 Reduced 1,417,473 -146,723 (-9.4%) 4.88% $191,153,321 2026-02-17
Q3 2025 New 1,564,196 +1,564,196 (0.0%) 3.78% $132,800,240 2025-11-14

Who else reported the position

350 managers reported ABIVAX SA for Q2 2026.

Managers reporting ABIVAX SA in Q2 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
TCG Crossover Management LLC Reduced 6,007,834 -473,251 19.24% $800,603,959 11 qtrs
Helikon Investments Ltd Added 2,787,131 +1,773,807 11.1% $371,413,077 2 qtrs
Darwin Global Management Ltd Added 3,621,583 +152,926 9.26% $348,215,205 4 qtrs
Vestal Point Capital LP Added 2,349,443 +849,443 7.32% $313,086,774 4 qtrs
Jupiter Topco LLC New 1,913,933 +1,913,933 0.1% $255,132,750 1 qtr
UBS Group AG Reduced 1,844,918 -2,702,488 0.03% $245,853,773 10 qtrs
ADAR1 Capital Management LLC Added 1,804,703 +410,684 11.01% $240,494,722 10 qtrs
Caligan Partners LP Added 1,557,924 +96,000 9.77% $207,608,952 7 qtrs
CITADEL ADVISORS LLC Added 1,438,352 +894,014 0.02% $191,674,788 11 qtrs
MORGAN STANLEY Reduced 1,432,185 -272,773 0.01% $190,852,973 11 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2026
Filed
August 14, 2026
Filing type
13F-HR
Position type
SPONSORED ADS

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.